Weiland O - Search Results

1

Heterosexual contact as a major route for transmission of acute hepatitis B among adults.

Struve J, Giesecke J, Lindh G, Weiland O. Struve J, et al. Among authors: weiland o. J Infect. 1990 Mar;20(2):111-21. doi: 10.1016/0163-4453(90)93288-4. J Infect. 1990. PMID: 2319144

2

Immunoglobulin prophylaxis against hepatitis A among Swedish UN soldiers in an endemic region.

Weiland O, Berg JV, Bäck E, Lundbergh P. Weiland O, et al. Infection. 1979;7(5):223-5. doi: 10.1007/BF01648930. Infection. 1979. PMID: 511340

3

Hepatitis C: virology, epidemiology, clinical course, and treatment.

Weiland O, Schvarcz R. Weiland O, et al. Scand J Gastroenterol. 1992 May;27(5):337-42. doi: 10.3109/00365529209000084. Scand J Gastroenterol. 1992. PMID: 1326784 Review. No abstract available.

4

Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test.

Mattsson L, Grillner L, Weiland O. Mattsson L, et al. Among authors: weiland o. Scand J Infect Dis. 1992;24(1):15-20. doi: 10.3109/00365549209048395. Scand J Infect Dis. 1992. PMID: 1375390

5

Intramuscular versus intradermal administration of a recombinant hepatitis B vaccine: a comparison of response rates and analysis of factors influencing the antibody response.

Struve J, Aronsson B, Frenning B, Granath F, von Sydow M, Weiland O. Struve J, et al. Among authors: weiland o. Scand J Infect Dis. 1992;24(4):423-9. doi: 10.3109/00365549209052627. Scand J Infect Dis. 1992. PMID: 1411307

6

Prevalence of hepatitis B virus markers in Sweden: a community-based serosurvey of 4,000 young Swedish adults.

Struve J, Giesecke J, Olcen P, von Sydow M, Weiland O. Struve J, et al. Among authors: weiland o. Am J Epidemiol. 1992 Feb 15;135(4):409-17. doi: 10.1093/oxfordjournals.aje.a116301. Am J Epidemiol. 1992. PMID: 1550092

7

Prevalence of hepatitis B virus markers and exposure to occupational risks likely to be associated with acquisition of hepatitis B virus among health care workers in Stockholm.

Struve J, Aronsson B, Frenning B, Forsgren M, Weiland O. Struve J, et al. Among authors: weiland o. J Infect. 1992 Mar;24(2):147-56. doi: 10.1016/0163-4453(92)92824-3. J Infect. 1992. PMID: 1569305

8

Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.

Schvarcz R, Glaumann H, Weiland O, Norkrans G, Wejstål R, Frydén A. Schvarcz R, et al. Among authors: weiland o. Liver. 1991 Feb;11(1):30-8. doi: 10.1111/j.1600-0676.1991.tb00487.x. Liver. 1991. PMID: 1646369 Clinical Trial.

9

Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden.

Mattsson L, Grillner L, von Sydow M, Bergdahl S, Weiland O. Mattsson L, et al. Among authors: weiland o. Infection. 1991 Sep-Oct;19(5):309-12. doi: 10.1007/BF01645353. Infection. 1991. PMID: 1666063

10

Ribavirin treatment for chronic hepatitis C.

Reichard O, Andersson J, Schvarcz R, Weiland O. Reichard O, et al. Among authors: weiland o. Lancet. 1991 May 4;337(8749):1058-61. doi: 10.1016/0140-6736(91)91707-2. Lancet. 1991. PMID: 1673493 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results